Depression in pulmonary arterial hypertension and interstitial lung diseases

Sameer Verma, Jose Cardenas-Garcia, Prasanta R. Mohapatra, Arunabh Talwar

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Advanced lung diseases such as pulmonary arterial hypertension (PAH) and interstitial lung diseases (ILD) are chronic diseases that cause significantly high morbidity and mortality As a result, patients can undergo some psychological changes leading to a poor quality of life and depression. Diagnosis of depression is often obscured because fatigue and apathy, two common symptoms of depression, frequently overlap with PAH and ILD. Healthcare providers are sometimes reluctant to ask or mistakenly believe that these symptoms are part of the ongoing disease process, rather than a serious condition like depression. Screening tools are available for physicians to be well positioned in recognizing clinical depression in PAH and ILD. A MedLine/PubMED search was performed identifying all relevant articles with "PAH", "ILD", "screening tools" and/or "Depression" in the title. The aim of this review is to provide a brief description of some of the instruments used to screen patients and classes of psychotropic medications accessible to physicians. While pulmonary rehabilitation programs can have a positive impact on patients, physicians should also utilize cognitive behavioral therapy (CBT) as part of regular care.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalNorth American Journal of Medical Sciences
Volume6
Issue number6
DOIs
StatePublished - Jun 2014

Fingerprint

Interstitial Lung Diseases
Pulmonary Hypertension
Depression
Physicians
Apathy
Cognitive Therapy
Health Personnel
Lung Diseases
Fatigue
Chronic Disease
Rehabilitation
Quality of Life
Psychology
Morbidity
Lung
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Verma, Sameer ; Cardenas-Garcia, Jose ; Mohapatra, Prasanta R. ; Talwar, Arunabh. / Depression in pulmonary arterial hypertension and interstitial lung diseases. In: North American Journal of Medical Sciences. 2014 ; Vol. 6, No. 6. pp. 1-10.
@article{2f14ef01789f4fb5a73d1e36d749b223,
title = "Depression in pulmonary arterial hypertension and interstitial lung diseases",
abstract = "Advanced lung diseases such as pulmonary arterial hypertension (PAH) and interstitial lung diseases (ILD) are chronic diseases that cause significantly high morbidity and mortality As a result, patients can undergo some psychological changes leading to a poor quality of life and depression. Diagnosis of depression is often obscured because fatigue and apathy, two common symptoms of depression, frequently overlap with PAH and ILD. Healthcare providers are sometimes reluctant to ask or mistakenly believe that these symptoms are part of the ongoing disease process, rather than a serious condition like depression. Screening tools are available for physicians to be well positioned in recognizing clinical depression in PAH and ILD. A MedLine/PubMED search was performed identifying all relevant articles with {"}PAH{"}, {"}ILD{"}, {"}screening tools{"} and/or {"}Depression{"} in the title. The aim of this review is to provide a brief description of some of the instruments used to screen patients and classes of psychotropic medications accessible to physicians. While pulmonary rehabilitation programs can have a positive impact on patients, physicians should also utilize cognitive behavioral therapy (CBT) as part of regular care.",
author = "Sameer Verma and Jose Cardenas-Garcia and Mohapatra, {Prasanta R.} and Arunabh Talwar",
year = "2014",
month = "6",
doi = "10.4103/1947-2714.134368",
language = "English (US)",
volume = "6",
pages = "1--10",
journal = "North American Journal of Medical Sciences",
issn = "2250-1541",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "6",

}

Depression in pulmonary arterial hypertension and interstitial lung diseases. / Verma, Sameer; Cardenas-Garcia, Jose; Mohapatra, Prasanta R.; Talwar, Arunabh.

In: North American Journal of Medical Sciences, Vol. 6, No. 6, 06.2014, p. 1-10.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Depression in pulmonary arterial hypertension and interstitial lung diseases

AU - Verma, Sameer

AU - Cardenas-Garcia, Jose

AU - Mohapatra, Prasanta R.

AU - Talwar, Arunabh

PY - 2014/6

Y1 - 2014/6

N2 - Advanced lung diseases such as pulmonary arterial hypertension (PAH) and interstitial lung diseases (ILD) are chronic diseases that cause significantly high morbidity and mortality As a result, patients can undergo some psychological changes leading to a poor quality of life and depression. Diagnosis of depression is often obscured because fatigue and apathy, two common symptoms of depression, frequently overlap with PAH and ILD. Healthcare providers are sometimes reluctant to ask or mistakenly believe that these symptoms are part of the ongoing disease process, rather than a serious condition like depression. Screening tools are available for physicians to be well positioned in recognizing clinical depression in PAH and ILD. A MedLine/PubMED search was performed identifying all relevant articles with "PAH", "ILD", "screening tools" and/or "Depression" in the title. The aim of this review is to provide a brief description of some of the instruments used to screen patients and classes of psychotropic medications accessible to physicians. While pulmonary rehabilitation programs can have a positive impact on patients, physicians should also utilize cognitive behavioral therapy (CBT) as part of regular care.

AB - Advanced lung diseases such as pulmonary arterial hypertension (PAH) and interstitial lung diseases (ILD) are chronic diseases that cause significantly high morbidity and mortality As a result, patients can undergo some psychological changes leading to a poor quality of life and depression. Diagnosis of depression is often obscured because fatigue and apathy, two common symptoms of depression, frequently overlap with PAH and ILD. Healthcare providers are sometimes reluctant to ask or mistakenly believe that these symptoms are part of the ongoing disease process, rather than a serious condition like depression. Screening tools are available for physicians to be well positioned in recognizing clinical depression in PAH and ILD. A MedLine/PubMED search was performed identifying all relevant articles with "PAH", "ILD", "screening tools" and/or "Depression" in the title. The aim of this review is to provide a brief description of some of the instruments used to screen patients and classes of psychotropic medications accessible to physicians. While pulmonary rehabilitation programs can have a positive impact on patients, physicians should also utilize cognitive behavioral therapy (CBT) as part of regular care.

UR - http://www.scopus.com/inward/record.url?scp=84902482570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902482570&partnerID=8YFLogxK

U2 - 10.4103/1947-2714.134368

DO - 10.4103/1947-2714.134368

M3 - Review article

C2 - 25006558

AN - SCOPUS:84902482570

VL - 6

SP - 1

EP - 10

JO - North American Journal of Medical Sciences

JF - North American Journal of Medical Sciences

SN - 2250-1541

IS - 6

ER -